0 NASDAQ Companies - November 8, 2018MagneGas Submits €2.5 Million Horizon 2020 Grant for Fourth Generation GasificationConsortium Includes Global Leaders in Renewable Energy Centers of Excellence TAMPA, Fla., Nov. 08, 2018 (GLOBE NEWSWIRE) — MagneGas Applied […]Read More
0 NASDAQ Companies - November 8, 2018Entera Bio Reports Positive Results from Part 1 of a Phase 2 PK/PD Study of Oral PTH (1-34) in Patients with Hypoparathyroidism– – – Demonstrates positive results in three metabolic parameters in patients with hypoparathyroidism treated with Oral PTH (1-34) – […]Read More
0 NASDAQ Companies - November 8, 2018TRHC and Landmark Announce Expansion of MedWise Medication Risk Mitigation StudyUse of TRHC’s MedWise Technology Suggests Promising Results in Reduced Hospital Admissions and Improved Cost Savings MOORESTOWN, N.J., Nov. 08, […]Read More
0 NASDAQ Companies - November 8, 2018Zscaler to Host First Quarter Fiscal 2019 Earnings Conference CallEarnings Results to be released on Tuesday, December 4, 2018, After the Close of the Market SAN JOSE, Calif., Nov. 08, […]Read More
0 NASDAQ Companies - November 8, 2018Icahn Enterprises L.P. Reports Third Quarter 2018 Financial ResultsFor the trailing twelve months ended September 30, 2018 indicative net asset value increased by $1.57 billion to $8.64 billion […]Read More
0 NASDAQ Companies - November 8, 2018Selecta Biosciences Announces Third Quarter 2018 Financial Results and Provides Corporate Update Prioritized head-to-head superiority clinical trial of SEL-212 compared to Krystexxa, expected to begin in the first quarter of 2019 as […]Read More
0 NASDAQ Companies - November 8, 2018Cisco Announces First Hybrid Solution for Kubernetes on Amazon Web ServicesSAN JOSE, Calif., Nov. 08, 2018 (GLOBE NEWSWIRE) — Applications are the lifeblood of business. Build them easily and get […]Read More
0 NASDAQ Companies - November 8, 2018Kezar Life Sciences Reports Third Quarter 2018 Financial Results and Provides Business UpdateSOUTH SAN FRANCISCO, Calif., Nov. 08, 2018 (GLOBE NEWSWIRE) — Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company […]Read More
0 NASDAQ Companies - November 8, 2018Aeglea BioTherapeutics Reports Third Quarter 2018 Financial Results and Recent Corporate HighlightsAUSTIN, Texas, Nov. 08, 2018 (GLOBE NEWSWIRE) — Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a clinical-stage biotechnology company that designs and develops […]Read More
0 TSX News - November 8, 2018Century Announces Filing of Second Quarter Financial Results, Management Discussion and AnalysisTHIS NEWS RELEASE IS NOT FOR DISTRIBUTION INTHE UNITED STATES OR TO U.S. NEWS AGENCIES TORONTO, Nov. 08, 2018 (GLOBE […]Read More